Unlocking the Potential of Therapeutics for Fibrosis & Oncology
Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. The Company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved physical properties, to develop new products in new indications that are, importantly, differentiated from the original (by way of dosage, delivery route or presentation), thus creating new and attractive commercial opportunities.
Nuformix has an early-stage pipeline of preclinical and Phase 1-ready assets with potential for significant value and early licensing opportunities.
Company Details
- Employees
- 4
- Address
- Virtual, Gb
- Phone
- +44 (0)1223 423 667
- nu****@****ons.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- nuformix.com
- Keywords
- Drug repurposing, Fibrosis, Oncology.
- HQ
- Virtual
Nuformix Plc Questions
Nuformix Plc's helpline number is +44 (0)1223 423 667
Nuformix Plc's website is nuformix.com
Nuformix Plc's LinkedIn profile is https://uk.linkedin.com/company/nuformix-plc
Nuformix Plc has
4 employees.
View email and phone details for 4
employees at Nuformix Plc.
Nuformix Plc's industry is
Pharmaceutical Manufacturing
Nuformix Plc's top competitors are
Zeb Nickel Corp.,
Kenai Limited,
Immupharma Plc,
River Biomedics,
Trio Medicines Ltd,
Qureight,
Oxilio,
Oncodrug Ltd,
Monument Therapeutics,
Trx Biosciences Limited.
Nuformix Plc's support email address is nuformix@gablecommunications.com
Nuformix Plc's categories are Pharmaceutical Manufacturing
